Structure, expression and regulation of the cannabinoid receptor gene (CB1) in Huntington's disease transgenic mice

European Journal of Biochemistry

Volumn 271, Issue 23-24, 2004, Pages 4909-4920

  McCaw, Elizabeth A ^a   Hu, Haibei ^a   Gomez, Geraldine T ^a   Hebb, Andrea L O ^a   Kelly, Melanie E M ^a   Denovan Wright, Eileen M ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Mutant huntingtin; Quantitative PCR; Striatum; Transcription initiation sites

Indexed keywords

CANNABINOID 1 RECEPTOR; HUNTINGTIN; MESSENGER RNA; RNA;

5' UNTRANSLATED REGION; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CHROMATIN STRUCTURE; CORPUS STRIATUM; EXON; FOREBRAIN; GENE EXPRESSION REGULATION; GENE STRUCTURE; GENETIC TRANSCRIPTION; GENOTYPE; HUNTINGTON CHOREA; INTRON; MOUSE; NERVE CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; QUANTITATIVE ANALYSIS; STEADY STATE; TIME; TRANSCRIPTION INITIATION SITE; TRANSGENIC MOUSE;

ANIMALS; BASE SEQUENCE; DNA; DNA PRIMERS; GENE EXPRESSION REGULATION; HUMANS; HUNTINGTON DISEASE; MICE; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS (GENETICS); PROTEIN CONFORMATION; RECEPTOR, CANNABINOID, CB1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEQUENCE HOMOLOGY, NUCLEIC ACID; TRANSCRIPTION, GENETIC;

ANIMALIA; EUKARYOTA; MUS MUSCULUS;

EID: 11244306357     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1432-1033.2004.04460.x     Document Type: Article

References (35)

1. Martin, J.B. & Gusella, J.F. (1986) Huntington's disease: pathogenesis and management. N. Engl. J. Med. 315, 1267-1276.
2. The Huntington's Disease Collaborative Research Group (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72, 971-983.
3. Trottier, Y., Biancalana, V. & Mandel, J.L. (1994) Instability of CAG repeats in Huntington's disease: relation to parental transmission and age of onset. J. Med. Genet. 31, 377-382.
4. Duyao, M.P., Auerbach, A.B., Ryan, A., Persichetti, F., Barnes, G.T., McNeil, S.M., Ge, P., Vonsattel, J.P., Gusella, J.F., Joyner, A.L. & MacDonald, M.E. (1995) Inactivation of the mouse Huntington's disease gene homolog Hdh. Science 269, 407-410.
5. Zuccato, C., Tartari, M., Crotti, A., Goffredo, D., Valenza, M., Conti, L., Cataudella, T., Leavitt, B.R., Hayden, M.R., Timmusk, T., Rigamonti, D. & Cattaneo, E. (2003) Huntingtin interacts with REST/NRSF to modulate the transcription of NRSE-controlled neuronal genes. Nat. Genet. 35, 76-83.
6. Glass, M., Faull, R.L.M. & Dragunow, M. (1993) Loss of cannabinoid receptors in the substantia nigra in Huntington's disease. Neuroscience 56, 523-527.
7. Richfield, E.K. & Herkenham, M. (1994) Selective vulnerability in Huntington's disease: preferential loss of cannabinoid receptors in lateral globus pallidus. Ann. Neurol. 36, 577-584.
8. A receptor alterations in the human basal ganglia in Huntington's disease. Neuroscience 97, 505-519.
9. Denovan-Wright, E.M. & Robertson, H.A. (2000) Cannabinoid receptor messenger RNA levels decrease in a subset of neurons in the lateral striatum, cortex and hippocampus of transgenic Huntington's disease mice. Neuroscience 98, 705-713.
10. Mangiarini, L., Sathasivam, K., Seller, M., Cozens, B., Harper, A., Hetherington, C., Lawton, M., Trottier, Y., Lehrach, H., Davies, S. & Bates, G. (1996) Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87, 493-506.
11. Naver, B., Stub, C., Moller, M., Fenger, K., Hansen, A.K., Hasholt, L. & Sorensen, S.A. (2003) Molecular and behavioral analysis of the R6/1 Huntington's disease transgenic mouse. Neuroscience 122, 1049-1057.
12. Hebb, A.L.O., Robertson, H.A. & Denovan-Wright, E.M. (2004) Striatal phosphodiesterase mRNA and protein levels are reduced in Huntington's Disease transgenic mice prior to the onset of motor symptoms. Neuroscience 123, 967-981.
13. Franklin, K.B.J. & Paxinos, G. (1997) The Mouse Brain in Stereotaxic Coordinates. Academic Press, San Diego.
14. Liu, R.Z., Denovan-Wright, E.M. & Wright, J.M. (2003) Structure, mRNA expression and linkage mapping of the brain-type fatty acid-binding protein gene (FABP7) from zebrafish (Danio rerio). Eur. J. Biochem. 270, 715-725.
15. Matsuda, L.A., Lolait, S.J., Brownstein, M.J., Young, A.C. & Bonner, T.I. (1990) Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346, 561-564.
16. Gerard, C.M., Mollereau, C., Vassart, G. & Parmentier, M. (1991) Molecular cloning of a human cannabinoid receptor which is also expressed in testis. Biochem. J. 279, 129-134.
17. Chakrabarti, A., Onaivi, E.S. & Chaudhuri, G. (1995) Cloning and sequencing of a cDNA encoding the mouse brain-type cannabinoid receptor protein. DNA Seq. 5, 385-388.
18. Luthi-Carter, R., Strand, A.D., Peters, N.L., Solano, S.M., Hollingsworth, Z.R., Menon, A.S., Frey, A.S., Spektor, B.S., Penney, E.B., Schilling, G., Ross, C.A., Borchelt, D.R., Tapscott, S.J., Young, A.B., Cha, J.-H.J. & Olson, J.M. (2000) Decreased expression of striatal signaling genes in a mouse model of Huntington's disease. Hum. Mol. Genet. 9, 1259-1271.
19. Luthi-Carter, R., Hanson, S.A., Strand, A.D., Bergstrom, D.A., Chun, W., Peters, N.L., Woods, A.M., Chan, E.Y., Kooperberg, C., Krainc, D., Young, A.B., Tapscott, S.J. & Olson, J.M. (2002) Dysregulation of gene expression in the R6/2 model of polyglutamine disease: parallel changes in muscle and brain. Hum. Mol. Genet. 11, 1911-1926.
20. Proudfoot, N.J., Furger, A. & Dye, M.J. (2002) Integrating mRNA processing with transcription. Cell 108, 501-512.
21. Steffan, J.S., Kazantsev, A., Spasic-Boskovic, O., Greenwald, M., Zhu, Y.-Z., Gohler, H., Wanker, E., Bates, G., Housman, D.E. & Thompson, L.M. (2000) The Huntington's disease protein interacts with p53 and CBP and represses transcription. Proc. Natl Acad. Sci. USA 97, 6763-6768.
22. Dunah, A.W., Jeong, H., Griffin, A., Kim, Y.-M., Standaert, D.G., Hersch, S.M., Mouradian, M.M., Young, A.B., Tanese, N. & Krainc, D. (2002) Sp1 and TAFII130 transcriptional activity disrupted in early Huntington's disease. Science 296, 2238-2243.
23. Li, S.-H., Cheng, A.L., Zhou, H., Lam, S., Rao, M., Li, H. & Li, X.-J. (2002) Interaction of Huntington's disease protein with transcriptional activator Sp1. Mol. Cell. Biol. 22, 1277-1287.
24. Yohrling, G.J., Farrell, L.A., Hollenberg, A.N. & Cha, J.H.J. (2003) Mutant huntingtin increases nuclear corepressor function and enhances ligand-dependent nuclear hormone receptor activation. Mol. Cell Neurosci. 23, 28-38.
25. Devane, W.A., Hanus, L., Breuer, A., Pertwee, R.G., Sevenson, L.A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A. & Mechoulam, R. (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258, 1946-1949.
26. Mechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N.E., Schatz, A.R., Gopher, A., Almog, S., Martin, B.R., Compton, D.R., Pertwee, R.G., Griffin, G., Bayewitch, M., Barg, J. & Vogel, Z. (1995) Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem. Pharmacol. 50, 83-90.
27. Glass, M. (2001) The role of cannabinoids in neurodegenerative diseases. Prog. Neuro-Psychopharmacol. Biol. Psychiat. 25, 743-765.
28. Carter, R.J., Lione, L.A., Humby, T., Mangiarini, L., Mahal, A., Bates, G.P., Dunnett, S.B. & Morton, A.J. (1999) Characterization of progressive motor deficits in mice transgenic for the human Huntington's disease mutation. J. Neurosci. 19, 3248-3257.
29. Hansson, O., Castilho, R.F., Korhonen, L., Lindholm, D., Bates, G.P. & Brundin, P. (2001) Partial resistance to malonate-induced striatal cell death in transgenic mouse models of Huntington's disease is dependent on age and CAG repeat length. J. Neurochem. 78, 694-703.
30. Meade, C.A., Deng, Y.P., Fusco, F.R., Del Mar., N., Hersch, S., Goldowitz, D. & Reiner, A. (2002) Cellular localization and development of neuronal intranuclear inclusions in striatal and cortical neurons in R6/2 transgenic mice. J. Comp. Neurol. 449, 241-269.
31. Cha, J.-H.J. (2000) Transcriptional dysregulation in Huntington's disease. Trends Neurosci. 23, 387-392.
32. van Roon-Mom, W.M., Reid, S.J., Jones, A.L., MacDonald, M.E., Faull, R.L. & Snell, R.G. (2002) Insoluble TATA-binding protein accumulation in Huntington's disease cortex. Brain Res. Mol. Brain Res. 109, 1-10.
33. Shelbourne, P.F., Killeen, N., Hevner, R.F., Johnston, H.M., Tecott, L., Lewandoski, M., Ennis, M., Ramirez, L., Li, Z., Iannicola, C., Littman, D.R. & Myers, R.M. (1999) A Huntington's disease CAG expansion at the murine Hdh locus is unstable and associated with behavioural abnormalities in mice. Hum. Mol. Genet. 8, 763-774.
34. Kennedy, L. & Shelbourne, P.F. (2000) Dramatic mutation instability in HD mouse striatum: does polyglutamine load contribute to cell-specific vulnerability in Huntington's disease? Hum. Mol. Genet. 9, 2539-2544.
35. Mathews, C.K., van Holde, K.E. & Ahern, K.G. (2000) Biochemistry, 3rd edn. Addison-Wesley Longman Inc, San Francisco, p. 1098.